LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Prevention of hemolytic transfusion reactions with intravenous immunoglobulin prophylaxis in U– patients with anti‐U

Photo by nci from unsplash

The U– phenotype is extremely rare and is found predominantly in black African populations at a frequency of between 0.2 and 1.7%. In European populations, U– units are therefore rare,… Click to show full abstract

The U– phenotype is extremely rare and is found predominantly in black African populations at a frequency of between 0.2 and 1.7%. In European populations, U– units are therefore rare, with limited availability in the United Kingdom. Anti‐U is clinically significant and is known to cause hemolytic transfusion reactions (HTRs) and hemolytic disease of the fetus and newborn. It has been suggested that intravenous immunoglobulin (IVIG) may be considered as an option among supportive therapy for urgent transfusion when clinically significant antigen‐matched units are not available. We report three cases with anti‐U transfused with least‐incompatible RBC units, their outcomes, and their clinical management.

Keywords: intravenous immunoglobulin; hemolytic transfusion; transfusion; reactions intravenous; prevention hemolytic; transfusion reactions

Journal Title: Transfusion
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.